<!DOCTYPE html>
<html manifest="manifest.manifest">
<head>
	<meta http-equiv=Content-Type content="text/html; charset=utf-8">
	<title>MRCG Clinical Guidelines</title>
	<meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=2.0, user-scalable=1">
  
	<meta name=Generator content="Microsoft Word 14 (filtered)">
		<link rel="stylesheet" href="jquery.mobile-1.4.5.min.css" />
	<link rel="stylesheet" href="mystyle.css" />
	<script src="jquery-1.11.1.min.js"></script>
	<script src="jquery.mobile-1.4.5.min.js"></script>
	<script type="text/javascript" src="cordova.js"></script>
	<script>
	    		$(function(){
			$("[data-role='header'], [data-role='footer']").toolbar();
		});
  	  $(document).one('pagebeforecreate', function () {
	        $('input[data-type="search"]').val("");
	    	        $.get("panel.html", function (data2) {
            $.mobile.pageContainer.prepend(data2);
              $("[data-role=panel]").panel().enhanceWithin();
        }, "html");
	           $.get("header.html", function (data) {
      $.mobile.pageContainer.prepend(data);
      $("[data-role='header']").toolbar().enhanceWithin();
    }, "html");
    $.get("footer.html", function (data) {
      $.mobile.pageContainer.append(data);
      $("[data-role='footer']").toolbar().enhanceWithin();
    }, "html");
        $('.WordSection1').wrap('<div role="main" class="ui-content">');
        $('table').wrap('<div class="tableCont"></div>');
        $('img').wrap('<div class="tableCont"></div>');
        $.mobile.pageContainer.enhanceWithin();
	  });
	        $(document).bind( "pagechange", function( ) {
        $('table').wrap('<div class="tableCont"></div>');
        $('img').wrap('<div class="tableCont"></div>');
        $('.tableCont').enhanceWithin();
      } );
			// When the user scrolls down 20px from the top of the document, show the button
		window.onscroll = function() {scrollFunction()};
		function scrollFunction() {
		  if (document.body.scrollTop > 20 || document.documentElement.scrollTop > 20) {
			document.getElementById("myBtn").style.display = "block";
		  } else {
			document.getElementById("myBtn").style.display = "none";
		  }
		}
		// When the user clicks on the button, scroll to the top of the document
		function topFunction() {
		  document.body.scrollTop = 0; // For Safari
		  document.documentElement.scrollTop = 0; // For Chrome, Firefox, IE and Opera
		}</script>      
	













  
  
  	
</head>
<body lang=EN-GB link=blue vlink=purple>
	
<div data-role="page">
	<div role="main" class="ui-content">
<div class=WordSection1>
<h1><span lang=EN-US>Infective Endocarditis</span></h1>
<h2><i><span lang=EN-US>Executive summary</span></i></h2>
<h2><span lang=EN-US>Introduction</span></h2>
<h2><span lang=EN-US style='font-size:11.0pt;font-weight:normal'>Infective
endocarditis (IE) refers to infection of the endocardial surface of the heart;
it usually refers to infection of one or more heart valves or infection of an
intracardiac device.</span></h2>
<h3><span lang=EN-US style='font-size:12.0pt;text-decoration:none'>Target users</span></h3>
<p class=MsoListParagraph style='margin-left:39.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Doctors</span></p>
<h3><span lang=EN-US style='font-size:12.0pt;text-decoration:none'>Target area
of use </span></h3>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Ward </span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>OPD</span></p>
<h3><span lang=EN-US style='font-size:12.0pt;text-decoration:none'>Key areas of
focus / New additions / Changes </span></h3>
<p class=MsoNormal><span lang=EN-US>This guideline focuses on the diagnostic
criteria and the anti- infective therapy for infective endocarditis. It covers
treatment of bacterial and fungal infective endocarditis.</span></p>
<p class=MsoNormal><span lang=EN-US>Users should take particular note of the
indications for surgical intervention. </span></p>
<h2><span lang=EN-US>Limitations</span></h2>
<p class=MsoNormal><span lang=EN-US>Patients requiring surgical intervention
may need to be referred to surgeons outside of the Gambia.</span></p>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
lang=EN-US style='font-size:12.0pt'>&nbsp;</span></b></p>
<h2><span lang=EN-US>Risk factors</span></h2>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Age &gt;60 years</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Male sex</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Poor dentition or dental infection</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Heart problem: Structural heart disease,
Valvular disease, Congenital heart disease</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Prosthetic valve</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>History of prior IE</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>HIV infection</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Injection drug use</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Chronic hemodialysis</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Intravascular device</span></p>
<h2><span lang=EN-US>Pathogen</span></h2>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><i><span lang=EN-US>S.aureus</span></i><span lang=EN-US> (31%)</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Viridans group streptococci (17%)</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Enterococci (11%)</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Coagulade-negative staphylococci (11%)</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><i><span lang=EN-US>Streptococcus bovis </span></i><span
lang=EN-US>(7%)</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Other streptococci (5%)</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Non-HACEK gram-negative bacteria (2%)</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Fungi (2%)</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>HACEK (2%): organisms in this category include a
number of fastidious gram-negative bacilli: <b><i>H</i></b><i>aemophilus
aphrophilus,</i> <b><i>A</i></b><i>ctinobacillus actinomycetemcomitans,</i> <b><i>C</i></b><i>ardiobacterium
hominis</i>; <b><i>E</i></b><i>ikenella corrodens</i>; and <b><i>K</i></b><i>ingella
kingae</i></span></p>
<h2><span lang=EN-US>Presenting symptoms and signs</span></h2>
<p class=MsoNormal><span lang=EN-US>Fever is the most common symptom (&gt; 90%).
It is often associated with chills, anorexia, and weight loss. </span></p>
<p class=MsoNormal><span lang=EN-US>Other common symptoms include malaise,
headache, myalgia, arthralgia, night sweats, abdominal pain, dyspnoea, cough,
and pleuritic pain. Note that these symptoms are non-specific and there may be
not much more than a sense that something is wrong.</span></p>
<p class=MsoNormal><span lang=EN-US>Patients with IE associated with dental
infection may report tooth pain or related symptoms.</span></p>
<h2><span lang=EN-US>Examination findings</span></h2>
<p class=MsoNormal><span lang=EN-US>Cardiac murmurs are the most common sign.
Supportive signs include splenomegaly and Cutaneous manifestations such as
petechiae or splinter hemorrhages. </span></p>
<p class=MsoNormal><span lang=EN-US>Relatively uncommon clinical manifestations
that are highly suggestive of IE include:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-US>Janeway lesions</span></b><span lang=EN-US> –
Nontender erythematous macules on the palms and soles.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-US>Osler nodes</span></b><span lang=EN-US> –
Tender subCutaneous violaceous nodules mostly on the pads of the fingers and
toes, which may also occur on the thenar and hypothenar eminences.</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-US>Roth spots</span></b><span lang=EN-US> –
Exudative, edematous hemorrhagic lesions of the retina with pale centers.</span></p>
<p class=MsoNormal><span lang=EN-US>Complications as presenting symptoms:</span></p>
<p class=MsoListParagraphCxSpFirst style='margin-left:54.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Cardiac complications (&gt;50%) – Valvular
insufficiency, heart failure, and others</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:54.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Neurologic complications (&gt;40%) – Embolic
stroke, intracerebral hemorrhage, brain abscess, and others</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:90.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>Septic emboli (&gt;25%) – Infarction of kidneys,
spleen, and other organs. In right-sided endocarditis, septic pulmonary emboli
may be seen.</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:90.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>Spleen embolic: radiating abdominal pain that
goes to the left shoulder</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:90.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>Renal: flank pain in the groin with possible pus
or blood in the urine</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:90.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>Brain (stroke): changes in neuro status,
confusion, speech difficulty</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:90.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>Pulmonary: chest pain, shortness of breath,
dyspnea, decreased oxygen saturation</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:54.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Metastatic infection – vertebral osteomyelitis,
septic arthritis, psoas abscess</span></p>
<p class=MsoListParagraphCxSpLast style='margin-left:54.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Systemic immune reaction – glomerulonephritis</span></p>
<p class=MsoNormal><b><span lang=EN-US style='font-size:12.0pt'>Diagnosis</span></b></p>
<p class=MsoNormal><span lang=EN-US>This is based on a combination of clinical
suspicion, the presence of risk factors, examination findings and the following
investigations:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Urine dipstick (looking especially for blood)</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>ECG</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>ECHO</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Blood cultures – 3 samples each from 2 or more different
sites at least 1 hour apart and ideally taking 10 ml of blood each time. These
must be completed before antibiotics are started.</span></p>
<p class=MsoNormal><span lang=EN-US>These results can be combined to formally
make a diagnosis of IE using modified Duke criteria. Note that some patients
will not meet these criteria in our setting, but will still have a high
suspicion of IE and no alternative treatable diagnosis, so will need to be
treated for IE anyway. </span></p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><u><span
lang=EN-US><span style='text-decoration:none'>&nbsp;</span></span></u></b></p>
<h3><span lang=EN-US>Modified Duke criteria</span></h3>
<div class="tableCont">
  <table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0 width=633
 style='width:474.65pt;border-collapse:collapse;border:none'>
 <tr>
  <td width=633 valign=top style='width:474.65pt;border:solid windowtext 1.0pt;
  background:#D9D9D9;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Major criteria</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=633 valign=top style='width:474.65pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='text-indent:5.5pt'><b><i><span lang=EN-US>Positive
  blood culture</span></i></b><span lang=EN-US> with common endocarditis
  pathogen (grown in 2 separate cultures)</span></p>
  </td>
 </tr>
 <tr>
  <td width=633 valign=top style='width:474.65pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='text-indent:5.5pt'><b><i><span lang=EN-US>Evidence
  of endocardial involvement</span></i></b><span lang=EN-US> either </span></p>
  <p class=MsoListParagraphCxSpFirst style='margin-left:21.0pt'><span
  lang=EN-US>Echocardiogram vegetation <b>OR</b></span></p>
  <p class=MsoListParagraphCxSpLast style='margin-left:21.0pt'><u><span
  lang=EN-US>New</span></u><span lang=EN-US> valvular regurgitation</span></p>
  </td>
 </tr>
 <tr>
  <td width=633 valign=top style='width:474.65pt;border:solid windowtext 1.0pt;
  border-top:none;background:#D9D9D9;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Minor criteria</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=633 valign=top style='width:474.65pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='text-indent:5.5pt'><span lang=EN-US>One of the risk
  factors</span></p>
  </td>
 </tr>
 <tr>
  <td width=633 valign=top style='width:474.65pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='text-indent:5.5pt'><span lang=EN-US>Fever (Documented
  temp =&gt; 38.0°C)</span></p>
  </td>
 </tr>
 <tr>
  <td width=633 valign=top style='width:474.65pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='text-indent:5.5pt'><b><i><span lang=EN-US>Vascular
  phenomena:</span></i></b><span lang=EN-US> major arterial emboli, septic
  pulmonary infarcts, mycotic aneurysm, intracranial hemorrhage, conjunctival
  hemorrhages, or Janeway lesions</span></p>
  </td>
 </tr>
 <tr>
  <td width=633 valign=top style='width:474.65pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='text-indent:5.5pt'><b><i><span lang=EN-US>Immunologic
  phenomena:</span></i></b><span lang=EN-US> Glomerulonephritis, Osler nodes,
  Roth spots, or rheumatoid factor</span></p>
  </td>
 </tr>
 <tr>
  <td width=633 valign=top style='width:474.65pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='text-indent:5.5pt'><b><i><span lang=EN-US>Microbiologic
  evidence:</span></i></b><span lang=EN-US> Positive blood cultures that do not
  meet major criteria <b>OR</b> serologic evidence of active infection with
  organism consistent with IE</span></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal style='text-indent:4.0pt'><b><span lang=EN-US
style='font-size:8.0pt'>&nbsp;</span></b></p>
<p class=MsoNormal style='text-indent:6.0pt'><b><span lang=EN-US
style='font-size:12.0pt'>Definite IE: </span></b><span lang=EN-US
style='font-size:12.0pt'>2 major criteria <i>or</i> 1 major + 3 minor criteria <i>or</i>
5 minor criteria</span></p>
<p class=MsoNormal style='text-indent:6.0pt'><b><span lang=EN-US
style='font-size:12.0pt'>Possible IE: </span></b><span lang=EN-US
style='font-size:12.0pt'>1 major + 1 minor criteria <i>or</i> 3 minor criteria</span></p>
<h2><span lang=EN-US>Management </span></h2>
<h3><span lang=EN-US>Antibiotic therapy</span></h3>
<div class="tableCont">
  <table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0 width=604
 style='width:453.35pt;border-collapse:collapse;border:none'>
 <tr>
  <td width=113 valign=top style='width:84.8pt;border:solid windowtext 1.0pt;
  background:#D9D9D9;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
  </td>
  <td width=246 valign=top style='width:184.25pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Native heart valve</span></b></p>
  </td>
  <td width=246 valign=top style='width:184.3pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Prosthetic heart valve(s)</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=113 valign=top style='width:84.8pt;border:solid windowtext 1.0pt;
  border-top:none;background:#D9D9D9;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>Empiric</span></p>
  <p class=MsoNormal><i><span lang=EN-US style='font-size:10.5pt'>(paediatric
  dosing)</span></i></p>
  </td>
  <td width=246 valign=top style='width:184.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>Ampicillin 2 g (<i>50
  mg/kg</i>) q4h IV <b>AND</b> </span></p>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>Gentamicin 3 mg/kg
  OD IV</span></p>
  </td>
  <td width=246 valign=top style='width:184.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>Ampicillin 2 g (<i>50
  mg/kg</i>) q4h IV <b>AND</b> </span></p>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>Gentamicin 5 mg/kg
  OD IV <b>AND</b> </span></p>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>Rifampicin 600 mg
  (<i>10 mg/kg</i>) BD PO</span></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
<p class=MsoNormal><u><span lang=EN-US>Note on usage of gentamicin for IE</span></u></p>
<p class=MsoNormal><span lang=EN-US>The gentamicin dose is adjusted from UK
guidelines (but is consistent with US / European guidelines) because we do not
have access to the therapeutic drug monitoring necessary to safely dose
gentamicin in a more than OD regimen.</span></p>
<p class=MsoNormal><span lang=EN-US>eGFR must be calculated as soon as possible
when gentamicin is started. If this is reduced below &lt; 50 ml/min, then the
dose of gentamicin should be reduced to by 50%. All patients expected to
receive gentamicin for more than 1 week must have their U&amp;Es checked 3
times per week and the gentamicin stopped as soon as there is any change in the
results.</span></p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><u><span
lang=EN-US><span style='text-decoration:none'>&nbsp;</span></span></u></b></p>
<h3><span lang=EN-US>Blood culture positive</span></h3>
<div class="tableCont">
  <table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0 width=604
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=113 valign=top style='width:84.55pt;border:solid windowtext 1.0pt;
  background:#D9D9D9;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>&nbsp;</span></b></p>
  </td>
  <td width=246 colspan=2 valign=top style='width:184.35pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Native heart valve</span></b></p>
  </td>
  <td width=246 colspan=2 valign=top style='width:184.45pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Prosthetic heart valve(s)</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=113 valign=top style='width:84.55pt;border:solid windowtext 1.0pt;
  border-top:none;background:#D9D9D9;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Pathogen</span></b></p>
  </td>
  <td width=170 valign=top style='width:127.6pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Dose </span></b><span lang=EN-US>(</span><i><span
  lang=EN-US style='font-size:10.5pt'>paediatric dosing)<b>)</b></span></i></p>
  </td>
  <td width=76 valign=top style='width:56.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Duration (weeks)</span></b></p>
  </td>
  <td width=170 valign=top style='width:127.7pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Dose </span></b><i><span lang=EN-US
  style='font-size:10.5pt'>paediatric dosing<b>)</b></span></i></p>
  </td>
  <td width=76 valign=top style='width:56.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Duration (weeks)</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=113 valign=top style='width:84.55pt;border:solid windowtext 1.0pt;
  border-top:none;background:#D9D9D9;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><i><span lang=EN-US style='font-size:10.5pt'>S.aureus </span></i><span
  lang=EN-US style='font-size:10.5pt'>(Methicillin sensitive)</span></p>
  </td>
  <td width=170 valign=top style='width:127.6pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>Cloxacillin 2 g
  (<i>50 mg/kg</i>) QDS IV</span></p>
  </td>
  <td width=76 valign=top style='width:56.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>4</span></p>
  </td>
  <td width=170 valign=top style='width:127.7pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>Cloxacillin 2 g
  (<i>50 mg/kg</i>) QDS IV <b>AND</b> </span></p>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>Rifampicin 600 mg
  (<i>10 mg/kg</i>) BD PO</span></p>
  </td>
  <td width=76 valign=top style='width:56.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>6</span></p>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>6</span></p>
  </td>
 </tr>
 <tr>
  <td width=113 valign=top style='width:84.55pt;border:solid windowtext 1.0pt;
  border-top:none;background:#D9D9D9;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>MRSA</span></p>
  </td>
  <td width=416 colspan=3 valign=top style='width:312.05pt;border-top:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>Requires
  vancomycin or teicoplanin and rifamipicin. Would be very difficult to treat
  in our setting.</span></p>
  </td>
  <td width=76 valign=top style='width:56.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=113 valign=top style='width:84.55pt;border:solid windowtext 1.0pt;
  border-top:none;background:#D9D9D9;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><i><span lang=EN-US style='font-size:10.5pt'>Streptococcus</span></i><span
  lang=EN-US style='font-size:10.5pt'> spp</span></p>
  </td>
  <td width=416 colspan=3 valign=top style='width:312.05pt;border-top:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>Benzylpenicillin
  2.4 g (<i>35 mg/kg</i>) q4h IV <b>AND</b></span></p>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>Gentamicin 3 mg/kg
  OD IV</span></p>
  </td>
  <td width=76 valign=top style='width:56.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>4-6</span></p>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>2</span></p>
  </td>
 </tr>
 <tr>
  <td width=113 valign=top style='width:84.55pt;border:solid windowtext 1.0pt;
  border-top:none;background:#D9D9D9;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><i><span lang=EN-US style='font-size:10.5pt'>Enterococcus</span></i></p>
  </td>
  <td width=416 colspan=3 valign=top style='width:312.05pt;border-top:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>Ampicillin 2 g (<i>30
  mg/kg</i>) q4h IV <b>AND</b></span></p>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>Gentamicin 3 mg/kg
  OD IV</span></p>
  </td>
  <td width=76 valign=top style='width:56.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>4-6</span></p>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>4-6</span></p>
  </td>
 </tr>
 <tr>
  <td width=113 valign=top style='width:84.55pt;border:solid windowtext 1.0pt;
  border-top:none;background:#D9D9D9;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>HACEK</span></p>
  </td>
  <td width=416 colspan=3 valign=top style='width:312.05pt;border-top:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>Ceftriaxone 2 g (<i>80
  mg/kg</i>) OD IV <b>AND</b></span></p>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>Gentamicin 3 mg/kg
  OD IV</span></p>
  </td>
  <td width=76 valign=top style='width:56.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>4-6</span></p>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>2</span></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
<h3><span lang=EN-US>Blood culture negative</span></h3>
<p class=MsoNormal><span lang=EN-US>It is not possible to distinguish between
different causes of blood culture negative IE in our setting. Therefore,
empiric treatment is used as below where good quality blood cultures taken
before antibiotic therapy are negative and there is suspicion of possible
infection with <i>Brucella</i>, <i>Coxiella burnetii</i> or <i>Bartonella</i>. Specialist
advice should be sought about this as soon as possible.</span></p>
<div class="tableCont">
  <table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0 width=604
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=113 valign=top style='width:84.65pt;border:solid windowtext 1.0pt;
  background:#D9D9D9;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Agent</span></b></p>
  </td>
  <td width=416 valign=top style='width:311.95pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Dose </span></b><span lang=EN-US>(</span><i><span
  lang=EN-US style='font-size:10.5pt'>paediatric dosing)</span></i></p>
  </td>
  <td width=76 valign=top style='width:56.75pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Duration (weeks)</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=113 valign=top style='width:84.65pt;border:solid windowtext 1.0pt;
  border-top:none;background:#D9D9D9;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>Empiric </span></p>
  </td>
  <td width=416 valign=top style='width:311.95pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>Doxycycline 200 mg
  (<i>4.4 mg/kg</i>) OD PO <b>AND</b></span></p>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>Ceftriaxone 2 g (<i>80
  mg/kg</i>) OD IV <b>AND</b></span></p>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>Gentamicin 3 mg/kg
  OD IV</span></p>
  </td>
  <td width=76 valign=top style='width:56.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>6 (may need to
  be longer)</span></p>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.5pt'>4</span></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal><span lang=EN-US>Note doxycycline cannot be used below the
age of 12 years. </span></p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><u><span
lang=EN-US><span style='text-decoration:none'>&nbsp;</span></span></u></b></p>
<h3><span lang=EN-US>Fungal endocarditis</span></h3>
<p class=MsoNormal><span lang=EN-US>Fungal endocarditis is most common in
patients with prosthetic valves, but also occurs in intravenous drug abusers,
neonates and immunocompromised patients.</span><span lang=EN-US> </span><span
lang=EN-US>Mortality is very high (50%), and treatment necessitates combined
antifungal administration and surgical valve replacement. </span></p>
<p class=MsoNormal><span lang=EN-US>Unfortunately, we do not have access to the
necessary drugs, so the best we can do is use high dose fluconazole.</span></p>
<div class="tableCont">
  <table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0 width=576
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=113 valign=top style='width:84.65pt;border:solid windowtext 1.0pt;
  background:#D9D9D9;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Agent</span></b></p>
  </td>
  <td width=170 valign=top style='width:127.75pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Primary</span></b></p>
  </td>
  <td width=151 valign=top style='width:4.0cm;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>After patient is stable</span></b></p>
  </td>
  <td width=142 valign=top style='width:106.3pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Duration</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=113 valign=top style='width:84.65pt;border:solid windowtext 1.0pt;
  border-top:none;background:#D9D9D9;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US style='font-size:10.0pt'>Dose</span></b><i><span
  lang=EN-US style='font-size:10.0pt'> (paediatric dosing)</span></i></p>
  </td>
  <td width=170 valign=top style='width:127.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Fluconazole 1200
  mg <i>(18 mg/kg) OD PO</i></span></p>
  </td>
  <td width=151 valign=top style='width:4.0cm;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Fluconazole 800 mg
  (12 mg/kg) OD PO</span></p>
  </td>
  <td width=142 valign=top style='width:106.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>For at least 6
  weeks after surgery</span></p>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>*For patients
  who cannot undergo valve replacement; lifelong</span></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
<p class=MsoNormal><span lang=EN-US>In case a patient has the means to purchase
more effective drugs, they would need to be given amphotericin and flucytosine.</span></p>
<p class=MsoNormal><b><span lang=EN-US>Indications for Surgery</span></b></p>
<p class=MsoNormal><span lang=EN-US>Ideally, a surgical opinion should be
sought for every patient with endocarditis. Unfortunately, this is not possible
here for most patients. However, it may be possible to discuss children with
endocarditis with the Chain of Hope team. The indications for surgery are
listed below.</span></p>
<div class="tableCont">
  <table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0 width=576
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=576 valign=top style='width:432.1pt;border:solid windowtext 1.0pt;
  background:#D9D9D9;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Heart Failure</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=576 valign=top style='width:432.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Aortic or mitral IE with:</span></p>
  <p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Severe acute regurgitation or valve
  obstruction</span></p>
  <p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Persistent heart failure</span></p>
  <p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Refractory pulmonary oedema / cardiogenic
  shock </span></p>
  </td>
 </tr>
 <tr>
  <td width=576 valign=top style='width:432.1pt;border:solid windowtext 1.0pt;
  border-top:none;background:#D9D9D9;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US style='font-size:10.5pt'>Uncontrolled infection</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=576 valign=top style='width:432.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
  lang=EN-US style='font-size:10.5pt;font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US style='font-size:10.5pt'>Abscess, false
  aneurysm, enlarging vegetation</span></p>
  <p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
  lang=EN-US style='font-size:10.5pt;font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US style='font-size:10.5pt'>Persisting fever and
  positive blood culture for &gt; 10 days after commencing appropriate
  antimicrobial therapy</span></p>
  <p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
  lang=EN-US style='font-size:10.5pt;font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US style='font-size:10.5pt'>Caused by fungi or
  multiresistant micro organisms</span></p>
  </td>
 </tr>
 <tr>
  <td width=576 valign=top style='width:432.1pt;border:solid windowtext 1.0pt;
  border-top:none;background:#D9D9D9;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US style='font-size:10.5pt'>Prevention of
  embolism</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=576 valign=top style='width:432.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
  lang=EN-US style='font-size:10.5pt;font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US style='font-size:10.5pt'>Large vegetations
  (&gt; 10 mm) + embolic episodes</span></p>
  <p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
  lang=EN-US style='font-size:10.5pt;font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US style='font-size:10.5pt'>Large vegetations
  (&gt; 10 mm) + other predictors of complicated cause</span></p>
  <p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
  lang=EN-US style='font-size:10.5pt;font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US style='font-size:10.5pt'>Very large vegetation
  (&gt; 15 mm)</span></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
<b><span lang=EN-US style='font-size:12.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span></b>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
lang=EN-US style='font-size:12.0pt'>&nbsp;</span></b></p>
<p class=MsoNormal><b><span lang=EN-US style='font-size:12.0pt'>Endocarditis
Prophylaxis</span></b></p>
<p class=MsoNormal><b><u><span lang=EN-US>Indication</span></u></b><span
lang=EN-US>: A cardiac condition AND a procedure</span></p>
<p class=MsoNormal><b><span lang=EN-US>Cardiac conditions</span></b><span
lang=EN-US>: Prosthetic valve, unrepaired cyanotic congenital heart disease, some
patients with repaired congenital heart disease (check online for current
guidance), previous infective endocarditis.</span></p>
<p class=MsoNormal><b><span lang=EN-US>Procedures</span></b><span lang=EN-US>: </span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>Dental procedure: manipulation of gingival tissue or periapical
region of teeth or perforation of the oral mucosa. </span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US>2.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>Respiratory procedure: incision or biopsy of respiratory mucosa.</span></p>
<p class=MsoNormal><b><span lang=EN-US>Regimens</span></b><span lang=EN-US>: Amoxicillin
2 g IV (Penicillin allergic: clindamycin 600 mg PO)</span></p>
<p class=MsoNormal><b><span lang=EN-US>Timing</span></b><span lang=EN-US>:
30-60 min before the procedures</span></p>
<h2><span lang=EN-US>Key Issues for Nursing care</span></h2>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Monitor vital signs especially temperature,
heart rate, blood pressure, oxygen saturation. </span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Educate the patient about:</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:52.5pt;text-indent:-18.0pt'><span
lang=EN-US>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>The need to inform other healthcare practitioners about history of
endocarditis because they are at risk for it again and will need prophylactic
antibiotics prior to invasive procedures</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:52.5pt;text-indent:-18.0pt'><span
lang=EN-US>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>How to take or administer antibiotics (complete all doses)</span></p>
<p class=MsoListParagraphCxSpLast style='margin-left:52.5pt;text-indent:-18.0pt'><span
lang=EN-US>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>The importance of good oral care.</span></p>
<h2><span lang=EN-US>References</span></h2>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Guidelines for the
diagnosis and antibiotic treatment of endocarditis in adults: Journal of
Antimicrobial Chemotherapy, Volume 67, Issue 2, 1 February 2012, Pages 269–289</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>2015 ESC
Guidelines for the management of infective endocarditis: European Heart Journal
(2015) 36, 3075–3123 doi:10.1093/eurheartj/ehv319</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Up to date:
Antimicrobial therapy of prosthetic valve endocarditis: last updated: Sep 06,
2018</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Up to date:
Clinical manifestations and evaluation of adults with suspected native valve
endocarditis last updated: Apr 27, 2018</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Up to date:
Epidemiology, risk factors, and microbiology of infective endocarditis: last
updated: Oct 26, 2018.</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Up to date:
Infective endocarditis in children: last updated: Nov 29, 2017.</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Endocarditis NCLEX
Review| Registered Nurse RN. com| NCLEX Review. Web. 19 Aug. 2016</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>&nbsp;</span></p>
<div class="tableCont">
  <table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Written by:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Name: Eriko Ikeda</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Date: 16 November 2018</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Reviewed by:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Name: Karen Forrest</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Date: 21 November 2018</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>&nbsp;</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Name: Thushan de Silva</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Date: 21 November 2018</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Version:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Change history:</span></b></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Review due date:</span></b></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>1.0</span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>New document</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>31 January 2021</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>1.1</span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Executive summary added</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>31 January 2021</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Review Comments (<i>if applicable)</i></span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>&nbsp;</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>&nbsp;</span></b></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
</div>
</div><!-- /content -->

</div>

</body>
</html>
